These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14252013)

  • 41. [EXPERIMENTAL USE OF 8909 RP, A NEW PHENOTHIAZINE COMPOUND, FOR THE TREATMENT OF MENTAL DISORDERS].
    TOMINAGA J; OKADA M; SUZUKI R; MATSUKI T
    Saishin Igaku; 1965 Jan; 20():236-9. PubMed ID: 14319011
    [No Abstract]   [Full Text] [Related]  

  • 42. MEGACOLON AND VOLVULUS IN PARKINSON'S DISEASE.
    CAPLAN LH; JACOBSON HG; RUBINSTEIN BM; ROTMAN MZ
    Radiology; 1965 Jul; 85():73-9. PubMed ID: 14303073
    [No Abstract]   [Full Text] [Related]  

  • 43. [PHARMACOLOGIC PRINCIPLES OF TREATMENT OF INTOXICATIONS WITH NEUROLEPTIC AND TRANQUILIZING AGENTS].
    TAESCHLER M; LOEW D
    Ther Umsch; 1965 Apr; 22():165-9. PubMed ID: 14297156
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical study on the combined action of a neuroleptic and antiparkinson drug].
    LAUNAY J; RUDRAUF J; CHALLOU C
    Ann Med Psychol (Paris); 1961 Jun; 119(2)():185-96. PubMed ID: 13759475
    [No Abstract]   [Full Text] [Related]  

  • 45. [Reasons for the use of mydocalm in the prevention and treatment of antibiotic-induced sensorineural hearing loss].
    Lantsov AA; Anichin VF; Alibekov IM
    Vestn Otorinolaringol; 1989; (5):15-20. PubMed ID: 2588406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. THE MANAGEMENT OF PARKINSONISM.
    STEVENS H
    Md State Med J; 1963 Oct; 12():494-7. PubMed ID: 14055262
    [No Abstract]   [Full Text] [Related]  

  • 47. EVALUATION OF A NEW PHENOTHIAZINE DERIVATIVE IN THE TREATMENT OF SCHIZOPHRENIA.
    GERZ HO
    Am J Psychiatry; 1964 Aug; 121():174-6. PubMed ID: 14194215
    [No Abstract]   [Full Text] [Related]  

  • 48. DYSTONIA PHENOTHIAZORUM.
    CHAMBERLIN RT; TREMBLY B
    J Maine Med Assoc; 1965 Feb; 56():30-1. PubMed ID: 14275191
    [No Abstract]   [Full Text] [Related]  

  • 49. [BENZTROPINE (COGENTIN) IN DRUG THERAPY OF THE PARKINSON SYNDROME].
    AVENARIUS HJ; GERSTENBRAND F
    Wien Klin Wochenschr; 1963 Dec; 75():924-6. PubMed ID: 14108932
    [No Abstract]   [Full Text] [Related]  

  • 50. [THE NEUROTROPIC SIDE-EFFECTS OF BUTYRROPHENONES].
    SABBATINI F
    Minerva Med; 1964 Mar; 55():675-6. PubMed ID: 14140239
    [No Abstract]   [Full Text] [Related]  

  • 51. [COMPARATIVE STUDIES ON THE EFFECT OF ANTIDEPRESSIVE AND NEUROLEPTIC DRUGS ON THE POWER OF CONCENTRATION].
    HARTUNG ML; BENTE D; SCHNEEWIND KA
    Arzneimittelforschung; 1964 Jun; 14():SUPPL:584-7. PubMed ID: 14253973
    [No Abstract]   [Full Text] [Related]  

  • 52. Use of Mydocalm in influencing the effect of muscle tremor on the ECG.
    SOLTI F
    Ther Hung; 1961; 9(3-4)():31-2. PubMed ID: 13978134
    [No Abstract]   [Full Text] [Related]  

  • 53. Observations with Mydocalm in angiological practice.
    Balogh A
    Ther Hung; 1981; 29(2):96-99. PubMed ID: 7188136
    [No Abstract]   [Full Text] [Related]  

  • 54. REPORT ON THE TREATMENT OF PSYCHOTIC PATIENTS WITH SORDINOL.
    SEGERS J; SCHUNZELAAR K; NUYTS SA
    Acta Neurol Psychiatr Belg; 1964 Jul; 64():746-52. PubMed ID: 14212721
    [No Abstract]   [Full Text] [Related]  

  • 55. UNDESIRABLE SIDE EFFECTS AND COMPLICATIONS WITH THE USE OF NEUROLEPTIC DRUGS.
    HAEEFNER H; HEYDER B; KUTSCHER I
    Int J Neuropsychiatry; 1965; 1():46-58. PubMed ID: 14314642
    [No Abstract]   [Full Text] [Related]  

  • 56. Observations with intensive Mydocalm treatment in neurological cases.
    Perényi G
    Ther Hung; 1987; 35(2):66-70. PubMed ID: 3326207
    [No Abstract]   [Full Text] [Related]  

  • 57. Procyclidine for dystonia caused by phenothiazine derivatives.
    PAULSON G
    Dis Nerv Syst; 1960 Aug; 21():447-8. PubMed ID: 14431032
    [No Abstract]   [Full Text] [Related]  

  • 58. DRUG-INDUCED PARKINSONIAN SYNDROME IN A CASE OF TRANQUILLIZER POISONING.
    LICHTIGFELD FJ
    Br J Psychiatry; 1964 Mar; 110():226-7. PubMed ID: 14130473
    [No Abstract]   [Full Text] [Related]  

  • 59. Assessment of drug therapy in Parkinsonism.
    ONUAGULUCHI G
    Br Med J; 1963 Feb; 1(5328):443-8. PubMed ID: 13940177
    [No Abstract]   [Full Text] [Related]  

  • 60. [CEREBRAL ELECTRICAL ANOMALIES ACCOMPANYING THE ONSET OR CESSATION OF NEUROLEPTIC TREATMENTS].
    SOULAIRAC A; GEIER S
    Encephale; 1964; 53():SUPPL:151-6. PubMed ID: 14161526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.